SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 62 filers reported holding SOLID BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | -25.0% | 24,687 | -2.6% | 0.00% | – |
| Q2 2022 | $16,000 | +60.0% | 25,344 | +190.6% | 0.00% | – |
| Q1 2022 | $10,000 | -87.2% | 8,722 | -80.4% | 0.00% | -100.0% |
| Q4 2021 | $78,000 | +66.0% | 44,411 | +124.2% | 0.00% | 0.0% |
| Q3 2021 | $47,000 | +51.6% | 19,806 | +131.0% | 0.00% | 0.0% |
| Q2 2021 | $31,000 | -83.7% | 8,575 | -75.1% | 0.00% | -66.7% |
| Q1 2021 | $190,000 | +475.8% | 34,466 | +684.2% | 0.00% | +200.0% |
| Q4 2020 | $33,000 | -42.1% | 4,395 | -84.2% | 0.00% | 0.0% |
| Q3 2020 | $57,000 | +280.0% | 27,830 | +450.8% | 0.00% | 0.0% |
| Q2 2020 | $15,000 | -74.6% | 5,053 | -62.1% | 0.00% | -80.0% |
| Q4 2019 | $59,000 | +490.0% | 13,348 | +1305.1% | 0.01% | +400.0% |
| Q3 2019 | $10,000 | -86.7% | 950 | -66.2% | 0.00% | -80.0% |
| Q4 2018 | $75,000 | +368.8% | 2,812 | +531.9% | 0.01% | +400.0% |
| Q2 2018 | $16,000 | -23.8% | 445 | -83.9% | 0.00% | -50.0% |
| Q1 2018 | $21,000 | – | 2,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,929,918 | $4,882,000 | 0.57% |
| Perceptive Advisors | 13,412,552 | $8,257,000 | 0.26% |
| Boxer Capital, LLC | 5,336,031 | $3,285,000 | 0.21% |
| RA Capital Management | 12,367,873 | $7,614,000 | 0.20% |
| K2 PRINCIPAL FUND, L.P. | 2,909,102 | $1,791,000 | 0.20% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,067,204 | $3,119,000 | 0.12% |
| Artal Group S.A. | 3,000,000 | $1,847,000 | 0.10% |
| Oasis Management Co Ltd. | 222,400 | $137,000 | 0.02% |
| Quantum Private Wealth, LLC | 37,271 | $22,000 | 0.01% |
| Laurion Capital Management LP | 1,156,600 | $712,000 | 0.01% |